Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Verdonck

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 1999
Dual nucleoside therapy in resource-poor and medium-income countriesR Colebunders, K Verdonck
AIDS (London, England)|June 5, 1999
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugsR Colebunders, K Verdonck
The Pediatric Infectious Disease Journal|August 10, 1999
Chemoprophylaxis for Pneumocystis carinii pneumoniaR Colebunders, D Denolf, K Verdonck
AIDS Patient Care and Stds|June 2, 2000
Impact of new developments in antiretroviral treatment on AIDS prevention and care in resource-poor countriesR Colebunders, K Verdonck, J Nachega, et al.
Lancet (London, England)|May 29, 1999
Sexual dysfunction with protease inhibitorsR Colebunders, E Smets, K Verdonck, et al.
Epidemiology and Infection|September 26, 2007
HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in PeruK Verdonck, E González, W Schrooten, et al.
Annals of the Rheumatic Diseases|January 10, 2002
Rheumatological complications associated with the use of indinavir and other protease inhibitorsE Florence, W Schrooten, K Verdonck, et al.
Mycoses|January 1, 1993
Effect of ferrioxamine on the growth of RhizopusA K Verdonck, J R Boelaert, B Z Gordts, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 9, 2008
Yield of fluorescence microscopy versus culture for tuberculosis at a middle-income country referral hospitalA Van Deun, R Chuquiyauri, G Torrea, et al.
Clinical and Experimental Immunology|October 13, 2006
Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in PeruI Best, V Adaui, K Verdonck, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 1999
Dual nucleoside therapy in resource-poor and medium-income countriesR Colebunders, K Verdonck
AIDS (London, England)|June 5, 1999
Reply to Gonzalez and Everall: Lest we forget: neuropsychiatry and the new generation anti-HIV drugsR Colebunders, K Verdonck
The Pediatric Infectious Disease Journal|August 10, 1999
Chemoprophylaxis for Pneumocystis carinii pneumoniaR Colebunders, D Denolf, K Verdonck
AIDS Patient Care and Stds|June 2, 2000
Impact of new developments in antiretroviral treatment on AIDS prevention and care in resource-poor countriesR Colebunders, K Verdonck, J Nachega, et al.
Lancet (London, England)|May 29, 1999
Sexual dysfunction with protease inhibitorsR Colebunders, E Smets, K Verdonck, et al.
Epidemiology and Infection|September 26, 2007
HTLV-1 infection is associated with a history of active tuberculosis among family members of HTLV-1-infected patients in PeruK Verdonck, E González, W Schrooten, et al.
Annals of the Rheumatic Diseases|January 10, 2002
Rheumatological complications associated with the use of indinavir and other protease inhibitorsE Florence, W Schrooten, K Verdonck, et al.
Mycoses|January 1, 1993
Effect of ferrioxamine on the growth of RhizopusA K Verdonck, J R Boelaert, B Z Gordts, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|April 9, 2008
Yield of fluorescence microscopy versus culture for tuberculosis at a middle-income country referral hospitalA Van Deun, R Chuquiyauri, G Torrea, et al.
Clinical and Experimental Immunology|October 13, 2006
Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in PeruI Best, V Adaui, K Verdonck, et al.
Pageof 2